EXC
47
2
GS
65
2
CL
77
2
NOV
37
-2
GM
61
-4
BMY
43
8
FOX
30
2
OKE
62
-2
XYL
43
-4
SWKS
57
-8
DE
29
-3
HPE
46
-5
HAL
41
11
K
30
-2
WY
27
-7
ZTS
49
20
INTU
69
4
MDT
44
5
FLS
50
-3
TRV
43
-3
EXC
47
2
GS
65
2
CL
77
2
NOV
37
-2
GM
61
-4
BMY
43
8
FOX
30
2
OKE
62
-2
XYL
43
-4
SWKS
57
-8
DE
29
-3
HPE
46
-5
HAL
41
11
K
30
-2
WY
27
-7
ZTS
49
20
INTU
69
4
MDT
44
5
FLS
50
-3
TRV
43
-3
Financhill
Back

Latch Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
15

LTCH
Latch

Last Price:
0.40
Seasonality Move:
-1.3%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
15
Latch (LTCH) is a Sell

Is Latch a Buy, Sell or Hold?

  • The current Latch [LTCH] share price is $0.40. The Score for LTCH is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • LTCH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LTCH Stock Price Chart

What is Latch's stock price today?

  • The Latch share price today is $0.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LTCH is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

LTCH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 43.05 Sell
Chaikin Money Flow: 81748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.48) Sell
Bollinger Bands (100): (0.47 - 0.81) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

LTCH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.42 Sell
20-day SMA: 0.44 Sell
50-day SMA: 0.49 Sell
200-day SMA: 0.73 Sell
8-day EMA: 0.42 Sell
20-day EMA: 0.44 Sell
50-day EMA: 0.5 Sell
200-day EMA: 0.73 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Latch Earnings Growth & LTCH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Latch Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):